期刊文献+

肿瘤相关性皮肌炎的^(18)F-FDG PET-CT影像特点 被引量:5

^(18)F-FDG PET-CT imaging characteristics of dermatomyositis associated with malignancy
下载PDF
导出
摘要 目的:探讨肿瘤相关性皮肌炎的18F-FDG PET-CT影像特点。方法:回顾性分析9例皮肌炎合并恶性肿瘤患者的临床资料和18F-FDG PET-CT显像资料,采用Mann-Whitney U秩和检验对恶性肿瘤病灶与骨骼肌的SUVmax的相关性进行统计学分析。9例中胆囊癌3例,肺癌2例,卵巢癌、食管癌、结肠癌及恶性淋巴瘤各1例。结果:所有恶性肿瘤病灶的18F-FDG摄取较高,SUVmax为7.26±5.48;7例患者18 F-FDG PET-CT显像示全身骨骼肌弥漫性对称性轻度摄取增高,SUVmax为3.45±0.81,与恶性肿瘤间差异有统计学意义(Z=-2.910,P=0.004)。同机CT扫描还发现1例合并间质性肺炎,3例合并肺部感染。结论:肿瘤相关性皮肌炎的18F-FDG PET-CT表现有一定特征性,认识其影像学表现,有助于提高对此病的诊断准确性。 Objective:To summarize the imaging characteristics of 18 F-FDG PET-CT in patients with dermatomyositis associated with malignancy. Methods: Retrospective analysis was made of clinical data and image data by whole body 18F- FDG PET-CT of 9 patients with dermatomyositis associated with malignancy. Results: Among 9 patients, there were 3 pa- tients with gallbladder carcinoma,2 patients with lung cancer, one patient with ovarian cancer, one patient with esophagus cancer,one patient with colon cancer, and one patient with lymphoma, respectively. All malignant lesions were 18F-FDG avid, the SUVmax, was 7.26±5.48. There was mild, diffuse and symmetrical increase of 18 F-FDG uptake in the muscles, the SUVmax was 3.45±0. 81. There was statistical difference of the 18F-FDG uptake between the lesions and muscles (Z=-2. 910,P=0. 004). In addition, 1 patient with interstitial pneumonia,and 3 patients with lung infections were diagnosed by CT. Conclusion:Clinicians and radiologists should be aware of the 18 F-FDG PET-CT imaging manifestations of dermato- myositis associated with malignancy in order to improve the diagnostic accuracy.
出处 《放射学实践》 2013年第12期1287-1290,共4页 Radiologic Practice
关键词 皮肌炎 恶性肿瘤 正电子发射型计算机断层扫描 18氟-氟代脱氧葡萄糖 体层摄影术 X线计算机 Dermatomyositis Malignant neoplasms Positron emission tomography Fluorine-18 fluoro-deoxyglu- cose Tomography,X-ray computed
  • 相关文献

参考文献12

  • 1Bohan AvPeter lB. Polymyositis and dermatomyositis[J]. N Engl J Med,1975,292(7) :344-347. 被引量:1
  • 2Buchbinder R, Forbes A, Hall S, et al. Incidence of malignant disease in biopsy-proven inflammatory myopathy-a population-based cohort study[J]. Ann Intern Med,2001, 134(2): 1087-1095. 被引量:1
  • 3Chen Yl . Wu CY, Huang YL,et al. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan[J]. Arthritis Res Ther,2010,12(2) :70. 被引量:1
  • 4Chen YJ, Wa CY,Shen JL,et al. Predicting factors of malignant in dermatomyositis and polymyositis: a case-control study [J]. Br J Dermatol , 2001,144(4) : 825-831. 被引量:1
  • 5Andras C, Ponyi A, Canstantin T, et al. Dermatomyositis and polymyositis associated with malignant: a 21-year retrospective study[J]. J Rheumatol , 2008,35(3) : 438-444. 被引量:1
  • 6Aznma K, Yamada H,Ohkubo M,et al. Incidence and predictive factors for malignant in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis [J]. Mod Rheumatol,2011,21(2) :178-183. 被引量:1
  • 7Ponyi A,Constantin T,Garami M,et al. Cancer-associated myositis: clinical features and prognostic signs[J]. Ann N Y Acad Sci, 2005,1051(1):64-71. 被引量:1
  • 8Tanaka S,Ikeda K, Uchiyama K,et al. 18F_FDG uptake in proximal muscles assessed by PET-CT reflected both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/ derm-atomyositis [J]. Rheumatology(Oxford) ,2013,11 (3) : 261-269. 被引量:1
  • 9Amerio P, Girardelli CR, Proietto G, et al. Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis[J]. Eur J Dermatol,2002,12(2) :165-169. 被引量:1
  • 10Fardet Lv Dupuy A,Gain M,et al. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis[J]. Medicine CBaltimore) ,2009 ,88( 2) : 91-97. 被引量:1

同被引文献62

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部